Prosecution Insights
Last updated: April 19, 2026

Shanghai Hengrui Pharmaceutical Co. Ltd.

12 pending office actions

Portfolio Summary

12
Total Pending OAs
2
Final Rejections
10
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18571909 FUSED TETRACYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF IN MEDICINE SHTERENGARTS, SAMANTHA L 1623 Non-Final OA Dec 19, 2023
18561111 PHARMACEUTICALLY ACCEPTABLE SALT OF PYRAZOLOHETEROARYL DERIVATIVE AND CRYSTAL FORM THEREOF RAO, PADMAJA S 1627 Non-Final OA Nov 15, 2023
18284654 TETRAHYDRONAPHTHALENE COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF IN MEDICINE BORALSKY, LUKE ALAN 1624 Non-Final OA Sep 28, 2023
18039683 PHARMACEUTICAL COMPOSITION COMPRISING ANTI-CONNECTIVE TISSUE GROWTH FACTOR ANTIBODY MACFARLANE, STACEY NEE 1675 Non-Final OA May 31, 2023
18032086 ANTI-HER3 ANTIBODY AND ANTI-HER3 ANTIBODY-DRUG CONJUGATE AND MEDICAL USE THEREOF STONEBRAKER, ALYSSA RAE 1642 Non-Final OA Apr 14, 2023
18023301 SIGNAL PEPTIDE FOR REDUCING END HETEROGENEITY OF HETEROLOGOUS POLYPEPTIDE GANGLE, BRIAN J 1645 Non-Final OA Feb 24, 2023
18018471 ANTI-PD-1 ANTIBODY PHARMACEUTICAL COMPOSITION AND USE THEREOF SWARTWOUT, BRIANNA KENDALL 1644 Non-Final OA Jan 27, 2023
18017388 SULFUR-CONTAINING ISOINDOLINE DERIVATIVE, AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF RZECZYCKI, PHILLIP MATTHEW 1625 Final Rejection Jan 20, 2023
18013231 ANTI-CD70 ANTIBODY AND APPLICATION THEREOF WEIDNER, ADAM M 1675 Non-Final OA Dec 27, 2022
17914087 PHARMACEUTICAL COMPOSITION COMPRISING ANTIBODY DRUG CONJUGATE AND USE THEREOF KIM, YUNSOO 1641 Final Rejection Sep 23, 2022
17794213 ANTI-ANGPTL3 ANTIBODY AND USE THEREOF SAOUD, CHRISTINE J 1645 Non-Final OA Jul 20, 2022
17793005 ANTI-TROP-2 ANTIBODY-EXATECAN ANALOG CONJUGATE AND MEDICAL USE THEREOF PUTTLITZ, KARL J 1646 Non-Final OA Jul 14, 2022

Managing Shanghai Hengrui Pharmaceutical Co. Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month